Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
Paid IBD clinical trials near you can be a sound next step if you are still flaring, offering access to new therapies, closer monitoring, and compensation when standard treatments fall short.
There are several factors to consider, including eligibility, safety oversight, possible side effects or placebo, visit demands, and how to coordinate with your GI and find active studies; see details below to choose the right next step.
If you're living with inflammatory bowel disease (IBD) — including Crohn's disease or ulcerative colitis — you already know that flares can disrupt every part of life. Persistent symptoms like abdominal pain, diarrhea, bleeding, urgency, and fatigue can continue even when you're taking prescribed medications.
If your current treatment is not working well enough, you may be wondering what to do next. One option many people overlook is enrolling in paid IBD clinical trials near me. These research studies offer access to new therapies while providing compensation for your time and participation.
Let's break down what this means, how it works, and whether it may be right for you.
IBD is a chronic autoimmune condition. That means your immune system mistakenly attacks your digestive tract, causing inflammation. While many medications are available — including biologics, immunomodulators, and anti-inflammatory drugs — not every patient responds fully.
You might still be flaring if you experience:
Some people lose response to medications over time. Others never achieve full remission.
If that sounds familiar, it may be time to explore additional options — including clinical research.
Clinical trials are carefully designed research studies that test:
When you search for paid IBD clinical trials near me, you are looking for studies recruiting participants in your area who may qualify.
These studies are conducted under strict medical oversight and follow detailed safety protocols. Before any treatment becomes publicly available, it must go through clinical trials to ensure safety and effectiveness.
Here are several reasons patients explore this option:
Clinical trials often offer medications not yet available to the public. If your current treatment plan isn't working, this may provide access to cutting-edge therapy.
Participants typically receive:
This level of monitoring can sometimes exceed routine care.
Most paid IBD clinical trials near me provide compensation. Payment may cover:
Compensation varies depending on the trial.
Today's IBD treatments exist because patients participated in earlier trials. Enrolling means helping improve care for others living with IBD.
This is a common and reasonable question.
Clinical trials in the United States and many other countries are regulated by:
Before enrolling, you will go through an informed consent process. This means:
That said, there are always potential risks. New treatments may:
No medical decision is risk-free — including staying on a treatment that isn't controlling inflammation.
This is why discussing participation with your gastroenterologist is essential.
Each trial has specific eligibility criteria. You may qualify if you:
Some trials require patients who have already tried biologics. Others are designed for people earlier in treatment.
If you're experiencing persistent symptoms and want to better understand your condition before discussing clinical trial options with your doctor, Ubie offers a free AI-powered symptom checker specifically for Ulcerative Colitis that can help you identify and track what you're experiencing.
While each study is different, most follow a similar process:
Some trials are placebo-controlled. That means some participants receive inactive treatment. However, many IBD trials now compare new therapies to existing treatments rather than placebo alone.
Ask detailed questions about study design before enrolling.
You might consider exploring this option if:
IBD inflammation that remains uncontrolled can lead to complications such as:
This is not meant to alarm you — but untreated or undertreated inflammation does carry real risks. Addressing persistent flares early is important.
Modern clinical trials follow structured phases. By the time most IBD drugs reach large patient trials, they have already undergone early safety testing.
You can withdraw from a study. You are not locked in.
Usually, your regular gastroenterologist remains involved in your care. Coordination between the research team and your primary GI doctor is common.
You can:
When reviewing a trial, ask:
If you're still flaring, doing nothing is rarely the best plan. Persistent inflammation can quietly cause damage even when symptoms feel manageable.
Exploring paid IBD clinical trials near me may offer:
Clinical trials are not the right choice for everyone. But for many patients with moderate to severe IBD, they are a legitimate and medically sound next step.
Before making any decision:
If you are experiencing severe abdominal pain, heavy rectal bleeding, high fever, dehydration, or signs of bowel obstruction, seek urgent medical care immediately.
For anything persistent, worsening, or potentially serious, speak to a doctor promptly. IBD is a complex disease, and medical guidance is essential.
You deserve relief — and if your current plan isn't getting you there, it may be time to look at what's next.
(References)
* Mao S, Zhang B, Shi C, Zhang M. Current and future therapeutic strategies for inflammatory bowel disease. *Ther Adv Gastroenterol*. 2019 Jun 25;12:1756284819857929. doi: 10.1177/1756284819857929. eCollection 2019.
* Vujasinovic M, Kupcinskas J, Rieder F, et al. Unmet needs in inflammatory bowel disease: current challenges and future directions. *Ther Adv Gastroenterol*. 2023 Nov 22;16:17562848231213038. doi: 10.1177/17562848231213038. eCollection 2023.
* Ungaro RC, Dubinsky MC. Therapeutic advances and unmet needs in inflammatory bowel disease. *Trends Pharmacol Sci*. 2023 Feb;44(2):87-101. doi: 10.1016/j.tips.2022.12.002. Epub 2023 Jan 3.
* Al-Dujaili Z, Ungaro RC. Emerging Therapies in Inflammatory Bowel Disease. *Gastroenterol Clin North Am*. 2023 Jun;52(2):373-393. doi: 10.1016/j.gtc.2023.01.002. Epub 2023 Apr 14.
* Shah M, Al-Dujaili Z, D'Anna K, et al. Patient Engagement in Clinical Trials for Inflammatory Bowel Disease. *Dig Dis Sci*. 2022 Jul;67(7):2787-2794. doi: 10.1007/s10620-022-07449-7. Epub 2022 Mar 10.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.